Intuitive Surgical, Inc. vs Palantir Technologies Inc — how do they compare? Intuitive Surgical, Inc. trades at $424 (market cap $146.76B), while Palantir Technologies Inc trades at $208 (market cap $477.68B). The key difference: Palantir Technologies Inc is far larger — about 3.3× Intuitive Surgical, Inc.'s market cap, and Palantir Technologies Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Palantir Technologies Inc for 78 Days on average.
| ISRG | PLTR | |
|---|---|---|
Market Cap | $146.76B | $477.68B |
Volume | 2,529,814 | 41,744,992 |
Sector | Health | Technology |
52-Week High | $592.85 | $207.18 |
52-Week Low | $332.02 | $107.27 |
Typical Hold Time | 84 Days | 78 Days |
Enterprise Value | $141.54B | $468.48B |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.
ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.
Palantir (PLTR) trades at $209.05, up 7.74% with strong bullish momentum as it approaches resistance at $209. The stock shows exceptional fundamental performance with 56.2% revenue growth in 2025, net income margin expanding to 36.3%, and consistent earnings beats. Recent partnership with Armada for sovereign AI infrastructure and positive analyst coverage support the upward trend, though valuation metrics remain elevated with P/E of 169.9 and P/S of 83.02.
Outlook remains positive given accelerating AI adoption and strong commercial growth (149% YoY US commercial revenue). Key risks include premium valuation sensitivity and competitive AI market pressures. Analyst consensus at $191.69 suggests potential near-term consolidation, but continued execution could justify higher multiples. Cash flow trends show strong operational performance despite significant investing outlays.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →